Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Half Year And Year Ended On March 31, 2022
Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Audited Financial Results For The Half Year And Year Ended On March 31, 2022 Global Longlife Hospital and Research Ltd - 543520 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant Shah Global Longlife Hospital and Research Ltd - 543520 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant Shah Global Longlife Hospital and Research Ltd - 543520 - Listing of equity shares of Global Longlife Hospital and Research Ltd
Trading Members of the Exchange are hereby informed that effective from May 04, 2022, the equity shares of Global Longlife Hospital and Research Ltd (Scrip Code: 543520) are listed and admitted to dealings on the Exchange in the list of ''MT'' Group Securities. For further details please refer to the notice no 20220502-23 dated May 02, 2022.